Movano Inc. (NASDAQ:MOVE) Sees Large Decrease in Short Interest

by · The Cerbat Gem

Movano Inc. (NASDAQ:MOVE – Get Free Report) was the recipient of a significant decline in short interest in the month of February. As of February 27th, there was short interest totaling 21,839 shares, a decline of 36.4% from the February 12th total of 34,360 shares. Based on an average trading volume of 46,049 shares, the short-interest ratio is presently 0.5 days. Currently, 2.1% of the shares of the company are sold short. Currently, 2.1% of the shares of the company are sold short. Based on an average trading volume of 46,049 shares, the short-interest ratio is presently 0.5 days.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on the company. Weiss Ratings reissued a “sell (e+)” rating on shares of Movano in a report on Thursday, January 22nd. Wall Street Zen upgraded shares of Movano from a “sell” rating to a “hold” rating in a research report on Saturday, February 28th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock presently has an average rating of “Sell”.

Check Out Our Latest Report on Movano

Movano Stock Performance

Movano stock traded up $0.21 on Friday, reaching $13.24. The company’s stock had a trading volume of 18,805 shares, compared to its average volume of 45,507. The business’s fifty day moving average price is $11.91 and its 200 day moving average price is $9.35. The company has a market cap of $15.12 million, a price-to-earnings ratio of -1.22 and a beta of 0.86. Movano has a twelve month low of $4.67 and a twelve month high of $34.87.

Trending Headlines about Movano

Here are the key news stories impacting Movano this week:

  • Positive Sentiment: Short‑term technical strength: the share price is trading above both its 50‑day ($11.82) and 200‑day ($9.30) simple moving averages, a signal that traders often treat as a buy trigger for momentum trades.
  • Positive Sentiment: Low float / micro‑cap dynamics can amplify small buy orders into visible price gains — helpful for quick upside when there’s even modest demand.
  • Neutral Sentiment: Healthcare/biotech headlines remain active (which can lift investor interest in small medical names), but recent items are about large-cap drugmakers and lifecycle plays rather than Movano specifically. Pfizer’s New Tafamidis Tablet Study Signals Strategic Lifecycle Move for PFE
  • Neutral Sentiment: Broader market sentiment pieces (e.g., on payments/tech or macro headlines) can shift risk appetite and small‑cap flows that move names like MOVE, but they’re indirect drivers. Why PayPal’s Rally Faded—And What Could Restart It
  • Neutral Sentiment: Geopolitical and commodity stories (oil/tankers, crypto volatility) are keeping overall market volatility elevated — that can produce intermittent demand for and selling of speculative small caps. Trump’s Move to Seize Oil Tankers Costs the U.S. Tens of Millions of Dollars
  • Negative Sentiment: Very light trading today (≈18.8k shares vs. ~1.24M average) means the move may be ephemeral — a handful of trades can swing the price on a micro‑cap.
  • Negative Sentiment: Company fundamentals remain a risk: tiny market cap, negative earnings, and a large 52‑week high/low spread imply high execution and liquidity risk for investors holding through volatility.

Insider Buying and Selling at Movano

In other news, CFO Jeremy Cogan sold 28,736 shares of the business’s stock in a transaction that occurred on Tuesday, January 27th. The stock was sold at an average price of $20.78, for a total transaction of $597,134.08. Following the sale, the chief financial officer directly owned 60,504 shares in the company, valued at approximately $1,257,273.12. The trade was a 32.20% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CTO Michael Aaron Leabman sold 6,845 shares of the company’s stock in a transaction on Wednesday, January 14th. The shares were sold at an average price of $6.66, for a total value of $45,587.70. Following the completion of the transaction, the chief technology officer owned 22,639 shares of the company’s stock, valued at $150,775.74. The trade was a 23.22% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 94,383 shares of company stock valued at $1,524,933 in the last quarter. Corporate insiders own 10.40% of the company’s stock.

Hedge Funds Weigh In On Movano

A hedge fund recently bought a new stake in Movano stock. Citadel Advisors LLC bought a new position in shares of Movano Inc. (NASDAQ:MOVE – Free Report) during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 49,262 shares of the technology company’s stock, valued at approximately $28,000. Citadel Advisors LLC owned approximately 5.94% of Movano at the end of the most recent quarter. 16.64% of the stock is currently owned by institutional investors.

Movano Company Profile

(Get Free Report)

Movano Health, Inc (NASDAQ: MOVE) is a health technology company focused on developing wearable devices for continuous biometric monitoring. The company’s core mission is to provide accessible, real-time health insights through noninvasive sensors, enabling individuals and care teams to track vital signs and physiological trends outside of traditional clinical settings.

Movano’s flagship product is a biometric monitoring ring designed to measure parameters such as heart rate, blood oxygen saturation, skin temperature, and sleep quality.

Further Reading